platinum has been researched along with tamoxifen in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarz, MA; Snyder, RD | 1 |
| Couzin, J | 1 |
| Bierbach, U; Ding, S; Kucera, GL; Qiao, X | 1 |
| Bierbach, U; Ding, S | 1 |
| Golding, TM; Mbaba, M; Smith, GS | 1 |
| Batema, GD; Gossage, RA; Guillena, G; Korstanje, TJ; Lutz, M; Rodríguez, G; van Klink, GPM; van Koten, G | 1 |
| Abdeddaim, C; Anota, A; Brocard, F; Cancel, M; Floquet, A; Frenel, JS; Hardy-Bessard, AC; Houlier, A; Kalbacher, E; Lardy-Cleaud, A; Largillier, R; Levaché, CB; Lortholary, A; Louvet, C; Meunier, J; Mouret-Reynier, MA; Pissaloux, D; Pop, O; Provansal, M; Ray-Coquard, I; Savoye, AM; Trédan, O; Treilleux, I; Venat-Bouvet, L; You, B; Zannetti, A | 1 |
1 review(s) available for platinum and tamoxifen
| Article | Year |
|---|---|
Recent Advances in the Biological Investigation of Organometallic Platinum-Group Metal (Ir, Ru, Rh, Os, Pd, Pt) Complexes as Antimalarial Agents.
Topics: Amines; Aminoquinolines; Animals; Antimalarials; Benzimidazoles; Coordination Complexes; Ferrous Compounds; HEK293 Cells; Humans; Imidazoles; Iridium; Ligands; Malaria; Metallocenes; Molecular Structure; Organometallic Compounds; Osmium; Palladium; Platinum; Quinolines; Rhodium; Ruthenium; Salicylates; Silanes; Tamoxifen; Thiosemicarbazones | 2020 |
1 trial(s) available for platinum and tamoxifen
| Article | Year |
|---|---|
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; CA-125 Antigen; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phenylurea Compounds; Platinum; Pyridines; Response Evaluation Criteria in Solid Tumors; Tamoxifen; Treatment Outcome | 2022 |
5 other study(ies) available for platinum and tamoxifen
| Article | Year |
|---|---|
Clinical trials in cancer medicine.
Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms | 1980 |
Choices--and uncertainties--for women with BRCA mutations.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Genes, BRCA1; Genes, BRCA2; Genetic Predisposition to Disease; Heterozygote; Humans; Mastectomy; Mutation; Ovarian Neoplasms; Ovariectomy; Platinum; Risk Assessment; Tamoxifen | 2003 |
Design of a platinum-acridine-endoxifen conjugate targeted at hormone-dependent breast cancer.
Topics: Acridines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Survival; DNA; Drug Design; Female; Humans; Intercalating Agents; MCF-7 Cells; Platinum; Receptors, Estrogen; Tamoxifen | 2013 |
Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.
Topics: Acridines; Amines; Antineoplastic Agents; Dendrimers; Indoles; Organophosphorus Compounds; Platinum; Quinazolines; Tamoxifen | 2016 |
Replacing the
Topics: Molecular Structure; Palladium; Platinum; Tamoxifen | 2021 |